Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases

Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases

Research on the antioxidant pathway comprising the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and its cytoplasmic inhibitor Kelch-like ECH-associated protein 1 (Keap1) is ever increasing. As modulators of this pathway have started to be used in clinical trials and clinic...

Full description

Bibliographic Details
Main Authors: Dionysios V. Chartoumpekis, Chun-Yan Fu, Panos G. Ziros, Gerasimos P. Sykiotis
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Antioxidants
Subjects:
nuclear factor erythroid 2-like factor 2 (Nfe2l2)
oxidative stress
text mining
patent landscape
autoimmunity
Online Access:https://www.mdpi.com/2076-3921/9/11/1138

Similar Items

Similar Items